Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7222 results

Helsinn links with Mundipharma to commercialize anamorelin in China

26-03-2015

Exclusive agreement broadens Helsinn’s existing partnerships for anamorelin in the area of cancer supportive…

anamorelinChinaHelsinnLicensingMundipharmaOncologyPharmaceutical

Parexel to acquire pharmacovigilance specialist Quantum Solutions India

Parexel to acquire pharmacovigilance specialist Quantum Solutions India

26-03-2015

Clinical research organization Parexel has signed a definitive agreement to acquire all of the business…

IndiaMergers & AcquisitionsParexelPharmaceuticalQuantum Solutions India

Shire and Cincinnati Children's Hospital collaborate on rare disease research

Shire and Cincinnati Children's Hospital collaborate on rare disease research

26-03-2015

Ireland-headquartered drugmaker Shire has entered into a three-year broad research collaboration for…

PharmaceuticalRare diseasesResearchShireUSA

Vical acquires novel antifungal from Astellas

26-03-2015

USA-based Vical saw its share leap 11.1% to $0.96 in after-hours trading yesterday, after it revealed…

Antibiotics and Infectious diseasesASP2397Astellas PharmaLicensingPharmaceuticalVical

Ablynx and Merck expand ion channel research collaboration

26-03-2015

Belgian drug developer Ablynx has expanded its initial two-year research collaboration with US pharma…

AblynxMerck & CoPharmaceuticalResearch

Novo Nordisk reports results of faster-acting insulin aspart and NovoRapid diabetes comparison

Novo Nordisk reports results of faster-acting insulin aspart and NovoRapid diabetes comparison

26-03-2015

Danish insulin giant Novo Nordisk has completed Phase IIIa trials comparing faster-acting insulin aspart…

DenmarkDiabetesNovo NordiskNovoRapidPharmaceuticalResearch

Transparency and cooperation help to reduce high prices for new medicines, WHO study shows

26-03-2015

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult…

EuropeHealthcarePharmaceuticalPricing

Sanofi Pasteur’s Quadracel vaccine gets FDA approval

26-03-2015

French pharma major Sanofi’s (Euronext: SAN) Sanofi Pasteur has received approval from the US Food…

PharmaceuticalQuadracelRegulationSanofiSanofi PasteurUSAVaccines

FDA approval for Emergent BioSolutions’ Anthrasil

25-03-2015

US biopharma company Emergent BioSolutions has received approval from the US Food and Drug Administration…

AnthrasilAntibiotics and Infectious diseasesEmergent BioSolutionsPharmaceuticalRegulationUSA

Global smart pills market to be worth $8.98 billion by 2024

25-03-2015

According to a new market research report, "Smart Pills Market by Application (Capsule Endoscopy, Drug…

GlobalMarkets & MarketingPharmaceutical

European Commission approves Santen Pharma’s Ikervis for eye disease

25-03-2015

Japanese drugmaker Santen Pharmaceutical has received approval of the Marketing Authorization Application…

EuropeIkervisOphthalmicsPharmaceuticalRegulationSanten Pharmaceuticals

AstraZeneca collaborates with Harvard Stem Cell Institute on beta cells

AstraZeneca collaborates with Harvard Stem Cell Institute on beta cells

25-03-2015

Anglo-Swedish drug major AstraZeneca has entered into a five-year research collaboration with the Harvard…

AstraZenecaDiabetesPharmaceuticalResearchSweden

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

24-03-2015

Limited data and the disparate nature of the datasets that are available have been challenges to measuring…

Markets & MarketingNephrology and HepatologyPharmaceuticalSocial IssuesUK

New enzalutamide presented by Astellas and Medivation at EAU

24-03-2015

Japanese pharma major Astellas Pharma and US drugmaker Medivation have presented new data from the Phase…

Astellas PharmaenzalutamideMedivationOncologyPharmaceuticalResearchXtandi

USA’s HHS seeks to develop improved anthrax vaccine

24-03-2015

Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer…

BioThraxEmergent BioSolutionsFinancialNuThraxPharmaceuticalResearchUSAVaccines

ThromboGenics announces positive data from 24-month followup study of Jetrea

ThromboGenics announces positive data from 24-month followup study of Jetrea

24-03-2015

Ophthalmic medicine specialist ThromboGenics has announced positive top-line results from its study of…

JetreaOphthalmicsPharmaceuticalResearchThromboGenics

Teva's anti-migraine drug TEV-48125 achieves primary and secondary endpoints at Phase IIb

Teva's anti-migraine drug TEV-48125 achieves primary and secondary endpoints at Phase IIb

24-03-2015

Israel-based Teva Pharmaceutical Industries says that its investigational drug TEV-48125 achieved the…

AnalgesiaIsraelNeurologicalPharmaceuticalResearchTEV-48125Teva

FDA safety review of Zyprexa Relprevv calls for no changes to current prescribing

24-03-2015

The US Food and Drug Administration has concluded a review of a study undertaken to determine the cause…

Eli LillyHealthcareNeurologicalPharmaceuticalRegulationUSAZyprexa Relprevv

97% of Australians want new cancer medicines subsidized through PBS

24-03-2015

New findings released by Newspoll shows overwhelming support for access to new cancer medicines through…

AustraliaFinancialHealthcareOncologyPharmaceutical

1 to 25 of 7222 results

Back to top